• Calcification
  • Hyperphosphatemia in itself doesn't cause any symptoms other than a hypocalcemic response due to increased Ca X P product which promotes soft tissue calcification. (oncologynurseadvisor.com)
  • We report here that components of the uremic state (activation of the receptor for advanced glycation end-products (RAGE) or hyperphosphatemia) potentiate vascular smooth muscle cell (VSMC) calcification by inducing persistent and exaggerated activity of mTORC1. (readbyqxmd.com)
  • Hyperphosphatemia is associated with increased cardiovascular risk, being a direct stimulus to vascular calcification. (wikipedia.org)
  • therapeutic
  • Global Markets Direct's, 'Hyperphosphatemia - Pipeline Review, H1 2014', provides an overview of the Hyperphosphatemia's therapeutic pipeline. (sbwire.com)
  • This report provides comprehensive information on the therapeutic development for Hyperphosphatemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. (sbwire.com)
  • It also reviews key players involved in the therapeutic development for Hyperphosphatemia and special features on late-stage and discontinued projects. (sbwire.com)
  • 250 mg, 500 mg), a therapeutic agent for hyperphosphatemia]. (readbyqxmd.com)